Evolution of the Average Target: Celanese Corporation

Evolution of the Target Price: Celanese Corporation

Changes in Analyst Recommendations: Celanese Corporation

8de3f748d0456ee8c927bbe2de9fe.vKUtA9D__nCW5k6ZJlUT5fAuDf8AHJatrlMIl_JPkII.2d1PaKOgjzTsigTSQDhbq6UDaLRxa8Pl7AVMpsAl9cmF1H9An4-pPvuqJQ~a8f12df612d0fe6b29f1c11d24124b04
03-09 Celanese Shares Rise After Tudor Pickering Holt Upgrade MT
03-09 Tudor Pickering Holt Upgrades Celanese to Buy From Hold, Raises Price Target to $65 From $55 MT
02-23 RBC Raises Price Target on Celanese to $55 From $48, Keeps Sector Perform Rating MT
02-19 UBS Adjusts Price Target on Celanese to $56 From $50, Maintains Neutral Rating MT
02-19 Deutsche Bank Adjusts Celanese Price Target to $62 From $52, Maintains Buy Rating MT
02-19 Analyst recommendations: Chewy, Garmin, T-Mobile US, Verizon, Booking… Zonebourse
02-18 Analyst recommendations: Costco, Amex, Draftkings, Humana, Vertiv… Zonebourse
02-05 Jefferies Upgrades Celanese to Buy From Hold, Adjusts Price Target to $86 From $43 MT
01-30 Analyst recommendations: Arista Networks, Dow, SouthWest Airlines, Coreweave, Meta Platforms… Zonebourse
01-20 Celanese's Q4 Earnings Likely to Hit Low End of Guidance Amid Acetyl Margin Pressure, Morgan Stanley Says MT
01-16 RBC Adjusts Price Target on Celanese to $48 From $43, Maintains Sector Perform Rating MT
01-12 UBS Adjusts Price Target on Celanese to $50 From $49, Maintains Neutral Rating MT
12-19 Wells Fargo Downgrades Celanese to Equal Weight From Overweight, Adjusts PT to $45 From $55 MT
11-12 UBS Lifts Price Target on Celanese to $49 From $48, Keeps Neutral Rating MT
14/10/25 BofA Adjusts Price Target on Celanese to $57 From $59, Maintains Buy Rating MT
14/10/25 RBC Trims Price Target on Celanese to $43 From $45, Keeps Sector Perform Rating MT
06/10/25 UBS Adjusts Price Target on Celanese to $48 From $49, Maintains Neutral Rating MT
02/10/25 Celanese Shares Rise After Citigroup Upgrade MT
02/10/25 Citigroup Upgrades Celanese to Buy From Neutral, Adjusts Price Target to $53 From $47 MT
14/08/25 RBC Capital Adjusts Price Target on Celanese to $45 From $63, Maintains Sector Perform Rating MT
14/08/25 RBC Capital Adjusts Price Target on Celanese to $45 From $63, Maintains Sector Perform Rating MT
14/08/25 Analyst recommendations: Allison, Celanese Corp, Coreweave, Cisco, Rockwell Automation… Zonebourse
13/08/25 Analyst recommendations: Avalonbay, Palo Alto, Vertiv, Fortinet, Nvidia… Zonebourse
12/08/25 UBS Cuts Celanese Price Target to $49 From $66, Maintains Neutral Rating MT
09/07/25 UBS Adjusts Price Target on Celanese to $66 From $51, Maintains Neutral Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+22.68%
+14.19%
+26.79%
+39.88%
+37.78%
+2.01%
+11.31%
+1.58%
+24.64%
-3%
Average +17.79%
Weighted average by Cap. +18.57%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
50.67USD
Average target price
63.12USD
Spread / Average Target
+24.57%
High Price Target
100.00USD
Spread / Highest target
+97.36%
Low Price Target
41.00USD
Spread / Lowest Target
-19.08%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Tudor Pickering Holt & Co.
RBC Capital Markets
UBS
Deutsche Bank Securities
Jefferies & Co.
Wells Fargo Securities
BofA Securities
Citigroup
BMO Capital
Mizuho Securities
KeyBanc Capital Markets
Alembic Global
Piper Sandler
Barclays
Morgan Stanley
Baird
JPMorgan Chase
Evercore ISI
Vertical Research
Stifel Nicolaus
Credit Suisse
Goldman Sachs
Wolfe Research
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
50.67USD
Average target price
63.12USD
Spread / Average Target
+24.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CE Stock
  4. Consensus Celanese Corporation
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW